Sun X, Jiao X, Pestell T G, Fan C, Qin S, Mirabelli E, Ren H, Pestell R G
1] Oncology Department of the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China [2] Departments of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Departments of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Oncogene. 2014 Oct 16;33(42):4967-77. doi: 10.1038/onc.2013.492. Epub 2013 Nov 18.
Emerging chemotherapy drugs and targeted therapies have been widely applied in anticancer treatment and have given oncologists a promising future. Nevertheless, regeneration and recurrence are still huge obstacles on the way to cure cancer. Cancer stem cells (CSCs) are capable of self-renewal, tumor initiation, recurrence, metastasis, therapy resistance, and reside as a subset in many, if not all, cancers. Therefore, therapeutics specifically targeting and killing CSCs are being identified, and may be promising and effective strategies to eliminate cancer. MicroRNAs (miRNAs, miRs), small noncoding RNAs regulating gene expression in a post-transcriptional manner, are dysregulated in most malignancies and are identified as important regulators of CSCs. However, limited knowledge exists for biological and molecular mechanism by which miRNAs regulate CSCs. In this article, we review CSCs, miRNAs and the interactions between miRNA regulation and CSCs, with a specific focus on the molecular mechanisms and clinical applications. This review will help us to know in detail how CSCs are regulated by miRNAs networks and also help to develop more effective and secure miRNA-based clinical therapies.
新兴的化疗药物和靶向疗法已广泛应用于抗癌治疗,为肿瘤学家带来了光明的前景。然而,肿瘤的再生和复发仍是癌症治愈道路上的巨大障碍。癌症干细胞(CSCs)具有自我更新、启动肿瘤、复发、转移、抵抗治疗的能力,并且在许多(即便不是所有)癌症中都作为一个亚群存在。因此,正在寻找特异性靶向并杀死CSCs的治疗方法,这可能是消除癌症的有前景且有效的策略。微小RNA(miRNAs,miRs)是一类以转录后方式调节基因表达的小非编码RNA,在大多数恶性肿瘤中表达失调,并被确定为CSCs的重要调节因子。然而,关于miRNAs调节CSCs的生物学和分子机制,我们所知有限。在本文中,我们综述了CSCs、miRNAs以及miRNA调节与CSCs之间的相互作用,特别关注分子机制和临床应用。这篇综述将帮助我们详细了解CSCs如何被miRNAs网络调节,也有助于开发更有效、更安全的基于miRNA的临床治疗方法。